Fronnt boosts its ambitious growth trajectory and energy transition mission with the entry of three new leading installation companies

GIMV

Fronnt, a group of installation companies founded in partnership with Gimv, welcomes three more leading installation companies. Besides the acquisition of Electro Verbeke in Deinze, Van Vooren/Setec in Bruges and TAC! (The Airconditioning Company) in Wilrijk join the group thanks to the pooling of forces with the investment company Tilleghem. Together they aim to accelerate the energy transition in Flanders.

Making buildings and industrial processes more energy efficient, electrifying heating and mobility, and implementing new technologies and business models are crucial to the success of the energy transition. For this, various technologies such as heat pumps, charging stations, solar panels and batteries must be able to interact with each other. Currently, this complexity is still too much placed on the customer. In response, Fronnt wants to completely unburden the customer by offering a multi-technical approach. To this end, Gimv and Fronnt bring together medium-sized installation companies, often of family origin, with a great deal of relevant knowledge and experience, based on the conviction that these forerunners, or “Fronntrunners”, can be even stronger in a larger context while retaining their own unique identity and customer service.

Fronnt was initially created in the first half of 2022 with the acquisitions of Lenaerts/LVR and ABN Klimatisatie. Not much later, Climawest and Sanitel also joined the group. Now, Fronnt is pleased to announce a further expansion of the group with the addition of Electro Verbeke, Van Vooren/Setec and TAC!. The acquisitions of the latter two companies came about through a joining of forces with the investment company Tilleghem. As a result, Tilleghem also becomes a shareholder of Fronnt to realise together with Gimv, the mission to make Fronnt the leading group of installation companies in Flanders.

Geert Fostier, CEO of Fronnt, on this important step forward: “Last year, in July, the first two companies jumped on the Fronnt-train, and shortly afterwards Climawest. With Van Vooren/Setec and Electro Verbeke we bring on board two companies specialised in electrical work, data systems and automation. TAC! (The Airconditioning Company) is a quality partner for HVAC and plumbing. Together with our existing companies, they further strengthen Fronnt’s DNA: guiding our customers through their energy transition by means of our integrated multi-technical approach. These three companies will find in Fronnt a large, stable and healthy group where they experience the benefits and operation of an SME.”

Ruben Monballieu, Partner at Gimv Sustainable Cities, adds: “These acquisitions mark an important step forward in our ambition to build a leading group of installation companies. We are excited about the growth trajectory we have achieved so far and look forward to further strengthening Fronnt and providing solutions to the challenges posed by the energy transition together with Tilleghem and all the passionate Fronnt entrepreneurs.”

Piet Van Waes, Partner at Tilleghem: “We are enthusiastic to join forces with Gimv, Fronnt and its cluster of strong installation companies. Our vision and strategy fit seamlessly with the path mapped out by the Fronnt managers and entrepreneurs. We share the ambition to build Fronnt into a sustainable and innovative player in the ecosystem of multifunctional installations and energy transition”.

 

Read the full document

Categories: News

Tags:

Waystone Group to acquire Link Fund Solutions

Montagu

24.04.2023

This transaction is a major milestone for both companies. Waystone’s goal is to work with investment managers and fund sponsors to build and support fund structures, and to protect the interest of fund investors. Today’s acquisition will boost Waystone’s ability to service a broader pool of investment managers and sponsors and bring a greater number of products and services to them.

The acquisition, which follows Waystone’s acquisition of T. Bailey Fund Services in 2022, will broaden Waystone’s UK offering to include alternative administration. In addition, it further expands the Group’s administration offering following its acquisition of Centaur Fund Administration in January 2023, together with a further strengthening of the Group’s Irish Management Company (“ManCo”) offering following the acquisition of KB Associates in 2022. It will also add over US$190bn in assets under oversight and administration, and see 600 staff globally join Waystone, including the establishment of the Group’s first office in India where it will now have around 150 employees.

By coming together with Waystone, the sponsors, investment managers and their underlying investors will benefit from a stable and sustainable foundation as Waystone continues to grow in Ireland, the UK and beyond, providing the opportunity to grow existing funds, launch new products and better serve their investors and the wider investment community.

Rachel Wheeler, CEO Global Management Company Solutions for Waystone, said: “We believe that Waystone is uniquely positioned to take LFS forward, providing quality global solutions to support its fund sponsors, investment managers and their underlying investors. We look forward to fully supporting the LFS team and enabling them to focus on continuing to provide exceptional service.”

We believe that Waystone is uniquely positioned to take LFS forward, providing quality global solutions to support its fund sponsors, investment managers and their underlying investors.

Rachel Wheeler, CEO Global Management Company Solutions, Waystone

Karl Midl, CEO of LFS, added: “We are delighted to be joining Waystone who are well known as a leading European fund services provider in our industry. The diversity of our client base requires significant investment in product enhancement – joining Waystone will allow us to further develop and expand our offering and invest in supporting our clients’ needs as they too continue to evolve and grow.  We look forward to working with Waystone to continue to build the confidence of asset managers, asset owners and investors in the fund market.”

We are delighted to be joining Waystone who are well known as a leading European fund services provider in our industry.

Karl Midl, CEO, LFS

Nancy Lewis, Executive Chairman, Waystone said: “The LFS acquisition further underscores Waystone’s strategic ambition of becoming a global leader in asset servicing. With our dual strategy of external and organic growth, driven by strong leadership and senior management, we will continue to expand our reach and deepen the quality of services we offer worldwide. We’d like to thank the teams involved at LFS, Waystone, the relevant Regulators, and all the other partners that have worked to successfully achieve this outcome.”

The LFS acquisition further underscores Waystone’s strategic ambition of becoming a global leader in asset servicing. With our dual strategy of external and organic growth, driven by strong leadership and senior management, we will continue to expand our reach and deepen the quality of services we offer worldwide.

Nancy Lewis, Executive Chairman, Waystone

Categories: News

CapMan to publish its 1 – 3 2023 Interim Report on Friday 28 April 2023

Capman

CapMan Plc press release                              

21 April 2023 at 11:45 a.m. EEST

CapMan to publish its 1 – 3 2023 Interim Report on Friday 28 April 2023

CapMan will publish its interim report for the period 1 January–31 March 2023 on Friday 28 April 2023 around 8.00 a.m. EEST. The company will present the results for the review period over a webcast press conference starting at 9.30 a.m. EEST accessible at https://capman.videosync.fi/2023-q1-results/. The conference will be held in English. The report and presentation material will be available at CapMan’s website after the publication (https://www.capman.com/shareholders/financial-reports/).

For further information, please contact:
Linda Tierala, Director, Communications and IR, tel. +358 40 571 7895, linda.tierala@capman.com

Webcast:
28 February 2023 at 9.30 a.m. EEST
https://capman.videosync.fi/2023-q1-results/
About CapMan
CapMan is a leading Nordic private asset expert with an active approach to value creation. As one of the private equity pioneers in the Nordics we have built value in unlisted businesses, real estate, and infrastructure for over three decades. With approx. €5  billion in assets under management, our objective is to provide attractive returns and innovative solutions to investors. We have set greenhouse gas reduction targets under the Science Based Targets initiative in line with the 1.5°C scenario. We have a broad presence in the unlisted market through our local and specialised teams. Our investment strategies cover minority and majority investments in portfolio companies and real estate, and infrastructure assets. We also provide wealth management solutions. Our service business includes procurement and analysis, reporting and back office services. Altogether, CapMan employs approximately 190 professionals in Helsinki, Stockholm, Copenhagen, Oslo, London and Luxembourg. We are listed on Nasdaq Helsinki since 2001. Learn more at www.capman.com

Categories: News

Herkules IV divests PTC to Interwell

Hercules Capital
On 21 April 2022, Herkules IV entered into an agreement to sell PTC, a global provider of downhole and wellhead technology products, to Interwell. Interwell is privately held provider of oilfield technology products, headquartered in Stavanger, Norway. Intwerell is owned by Ferd and the Interwell management.
PTC is a leading developer and supplier of premium gas lift and wellhead products that enhance well integrity, safety, reliability and productivity for oil companies. The company has a large, patent protected product portfolio developed in close relationship with customers facing well-related challenges offshore. Herkules has owned the company together with the founders and other employees.During Herkules IV’s ownership period, PTC has grown revenues from NOK 202 million in 2013 to NOK 502 million in 2021. In this period, the company has experienced two major industry downturns and a global pandemic that has had material negative impacts on the company.
In 2014-2016, the company experienced the first industry downturn during Herkules IV’s ownership. During this period, it was decided that the company was to continue to invest in developing and expanding its portfolio of unique technology products. In addition, the company was to invest in obtaining industry leading safety and quality certifications on its products. The decision to continue to invest during those challenging times has proven to a key factor in the company’s success since 2016. Since 2016, PTC has successful expanded its addressable market and gained momentum in several new markets

Categories: News

Tags:

Retein closes SEK 11 million financing round to enable efficient recovery of clean water

Industriefonden

The Swedish company Retein that has developed a patented technology for water separation today announced the successful closing of their latest financing round. The company is being backed by IndustrifondenButterfly Ventures, Navigare Ventures, and existing owner Chalmers Ventures. The new financing will bring their technology one step closer to industry and people in need.

Retein, until recently named Aquammodate, was founded in 2019 and has developed a patented technology for energy-efficient and high purity water separation. The technology has the potential to reduce the cost for recovering clean water and have lower impact on the environment than traditional methods. The new investment will be used to increase the production of stabilized aquaporins and finalize the development of a filtration module with embedded aquaporins.

Simon Isaksson, co-founder and CEO at Retein, said: We are excited to welcome Industrifonden, Butterfly Ventures, and Navigare Ventures on board our journey towards enabling sustainable reuse of resources such as clean water. Their extensive experience in scaling and advancing deep tech solutions adds additional strength on our path to realize the transformational potential of our solution”.

The patented molecular separation technology was initially developed over the course of Simon Isaksson’s PhD project under the supervision of Retein co-founder professor Martin Andersson, at Chalmers University of Technology. The foundation of the technology is a biomimetic approach to water separation, as the company has taken inspiration by how aquaporins function in diatoms. The proprietary silica stabilization allows the aquaporins to be used as an additive to various kinds of filters on a wide range of scales.

Iliam Barkino, Principal at Industrifonden, said: “We’re proud to back the team at Retein and their unique technology based on impressive science from Chalmers University of Technology. They are truly unique in the way they have been able to stabilize aquaporins in a similar way that algae do, and we believe in the team that has a mix of highly qualified technological expertise and entrepreneurial experience.”

Learn more at retein.tech ↗

Categories: News

Tags:

EQT Private Equity to sell kfzteile24, a leading eCommerce platform for automotive spare parts and accessories in Germany

eqt

EQT Private Equity sells kfzteile24 to an investment consortium consisting of the Company’s Management, Project A Ventures, Koehler Group and a group of technology investors (“SB21”)

Under EQT’s ownership, kfzteile24 has made substantial investments in its digital platform and logistics infrastructure to support its growth trajectory and operational efficiency

The Company has expanded its online offering from around one million to around three million products, has significantly grown its B2B customer base and also initiated international expansion

EQT is pleased to announce that the EQT Mid Market fund (“EQT Private Equity”) has agreed to sell kfzteile24 (the “Company”) to an investment consortium consisting of the Company’s Management, Project A Ventures, Koehler Group and a group of technology investors (“SB21”).

Founded in 2001 and headquartered in Berlin, kfzteile24 is a leading eCommerce platform for automotive spare parts and accessories in Germany. In addition to its online webshop and app, kfzteile24 operates three retail stores with affiliated repair shops in Berlin to supplement the online distribution. kfzteile24 is positioned within the large independent automotive aftermarket, which sees a healthy and steady growth outlook driven by increasing online adoption and a growing and aging car fleet in Germany.

EQT Private Equity acquired kfzteile24 from its founders in October 2015. During EQT’s ownership, kfzteile24 has made substantial investments in its digital platform and logistics infrastructure to support its growth trajectory and operational efficiency. The Company has expanded its online offering from around one million to around three million products (including one of the largest online e-mobility product range in Germany), has significantly grown its B2B customer base, and also initiated international expansion.

Vesa Koskinen, Partner within EQT Private Equity’s Advisory Team, said, “The Company’s management team has played an instrumental role in developing kfzteile24 to a leading digital automotive spare parts platform with excellent operational capabilities. We believe kfzteile24 is in great hands and has a bright future ahead.”

Markus Winter, CEO of kfzteile24, said “We are very grateful for EQT’s extensive support, which enabled us to turn kfzteile24 into the successful and profitable omnichannel company it is today. Our strong digital platform has been key to the rapid expansion of the direct delivery business for commercial customers. EQT has been a great partner and helped to position kfzteile24 for the long-term. We are excited for what the future holds.”

The closing of the transaction took place on 20 April 2023.

Contact

EQT Press Office, press@eqtpartners.com, +46 8 506 55 334

Categories: News

Tags:

BURE comments on the merger between ACQ BURE AB and YUBICO AB

Bure

Based on today’s information regarding the merger between ACQ Bure AB (“ACQ”) and Yubico AB (“Yubico”), Bure’s ownership in Yubico after completion of the transaction will increase to 17.4% given the terms and assumptions set out in ACQ’s press release.

  • The Swedish acquisition company ACQ was established on the initiative of Bure Equity (“Bure”) and was listed on Nasdaq Stockholm in March 2021. ACQ has focused on finding an unlisted, sustainable, Nordic technology-based quality company that operates in a market with strong potential or in a niche market where the target company has a leading position.
  • Yubico is a global leading provider of hardware-based multi-factor authentication solutions, which protects against use of stolen identities. Yubico was founded in 2007 by Stina and Jakob Ehrensvärd, and its customer base spans approximately 160 countries. To date, the company’s core product, the YubiKey, has been sold in over 22 million units worldwide and it is currently used by many of the world’s largest enterprises.
  • Bure owns 20% in ACQ since 2021 and has been an owner of Yubico since 2017, when Bure acquired a minority stake. Since 2017, Bure has continued to invest in Yubico and today, Bure has an ownership stake of 15.3% in the company on a fully-diluted basis. Following the merger between ACQ and Yubico, Bure’s ownership in the combined company, which will change name to Yubico, will amount to 17.4% (given the terms and assumptions set out in ACQ’s press release). Hence, Bure will become the company’s largest shareholder.
  • As an owner of both Yubico and ACQ, Bure has a conflict of interest. Patrik Tigerschiöld and Sarah McPhee, board members of both Bure and ACQ, as well as Henrik Blomquist, the CEO of both Bure and ACQ, have therefore not participated, and will not participate, in the board of ACQ‘s resolutions to approve of the transaction or enter into the merger plan and the merger agreement, nor have they participated in the board’s deliberations regarding such resolutions. The non-conflicted board members in ACQ’s board of directors have thus managed the resolutions, and the deliberations regarding the resolutions, concerning the transaction.
  • The final decision on whether the transaction should be completed will be made by ACQ’s shareholders at ACQ’s extraordinary general meeting around June 20, 2023.
  • Bure is supporting the merger and has committed to vote in favour of the merger at the extraordinary general meetings.
  • Bure has accepted a lock-up period of 365 days from the date of completion of the transaction, meaning Bure has accepted to not sell its shareholding in ACQ during this period. The transaction is expected to be completed during the third quarter of 2023.
  • The merger consideration to the shareholders in Yubico consists of 42% payment in cash and 58% payment in newly issued shares in ACQ. As a shareholder in Yubico, Bure will receive 8,064,674 new shares in ACQ, and SEK 579 million in cash. Bure thereby has 15,064,674 shares after the transaction and hence increases its ownership in Yubico of 15.3% to 17.4% after completion of the merger.
  • As a sponsor in ACQ, Bure holds 4,200,000 sponsor warrants in the merged company. The sponsor warrants can be exercised for subscription of shares no earlier than 1 April 2026 and no later than 1 April 2031 with a strike price of SEK 130. This means that Bure can reach a maximum ownership of 21.2% in Yubico.
  • Bure intends to propose Patrik Tigerschiöld as Chairman of the Board of Yubico.

Patrik Tigerschiöld, Chairman of the Board of Bure, comments:

“Stina and Jakob Ehrensvärd have been extremely successful entrepreneurs and company builders, as they have developed Yubico into a world-leading player in the global cybersecurity market. I am very pleased that a quality company like Yubico chooses to become listed in Sweden, and I am looking forward to continuing the Yubico journey together with its founders, employees, and other shareholders”.

“The fact that Bure has been an owner of Yubico since 2017 has added a layer of complexity in the transaction process. Given the circumstances, special requirements have been placed on the decision-making process and deliberations. The non-conflicted members of ACQ’s board have been responsible for making the decisions concerning the transaction, while Bure’s representatives with conflicts of interest have not been involved in these particular activities. Lastly, it is important to note that the final decision on whether the transaction should be carried out will be made by ACQ’s shareholders at the extraordinary general meeting”.

Categories: News

Gilde Healthcare raises €600 million to invest in healthcare innovation

GIlde Healthcare
  • A balanced mix of international investors commits €600 million to Gilde Healthcare Venture&Growth VI, a transatlantic investment fund
  • Gilde Healthcare invests in fast growing companies that enable better care at lower cost, supported by its recently appointed Impact Council
  • In three years’ time, Gilde Healthcare raised over €1.5 billion across three funds

Gilde Healthcare today announces a new investment fund with €600 million in commitments: Gilde Healthcare Venture&Growth VI. The new fund focuses on fast growing companies developing solutions for better care at lower cost. Gilde Healthcare invests in companies in Europe and North America active in digital healthcare, medical technology (MedTech) and therapeutics.

The fund is backed by a balanced mix of international investors, including corporates, banks, pension funds, insurers, fund-of-funds, sovereign wealth funds, endowments, family offices, entrepreneurs and the Gilde team.

Pieter van der Meer, Managing Partner at Gilde Healthcare: “We are pleased with the strong interest from investors who support our mission. Innovations that improve the quality of care but also keep it affordable are essential to ensure access to healthcare. Our broad strategy, covering digital health, MedTech and therapeutics, results in a holistic approach allowing us to select the most optimal and cost effective solution for the individual patient. With a team of sector experts, we help companies to further scale medical innovations and to make them accessible globally.”

The healthcare expenditure in the Western World continues to grow, already exceeding 20% of GDP in the United States. Gilde Healthcare’s mission to invest in better care at lower cost, is supported by the recently established Impact Council, chaired by the former executive director of the European Medicines Agency (EMA).

The new fund will invest €10-60 million per new portfolio company. Together with the last Venture&Growth fund (closed in 2020) and Gilde Healthcare Private Equity IV (closed in 2022), Gilde Healthcare has raised €1.5 billion in capital over the last three years.

Media contact:
Ruben Cardol (media contact)
email: ruben.cardol@cffcommunications.nl
phone: +31 (0)6 55 358 427

Pieter van der Meer (Managing Partner)
email: vandermeer@gildehealthcare.com
phone: +31 30 219 2565

About Gilde Healthcare
Gilde Healthcare is a specialized healthcare investor managing over €2.5 billion across two fund strategies: Venture&Growth and Private Equity. The Venture&Growth fund of Gilde Healthcare invests in fast growing companies active in digital health, medtech and therapeutics, based in Europe and North America. The Private Equity fund of Gilde Healthcare participates in profitable lower mid-market healthcare companies based in North-Western Europe. For more information, visit the company’s website at www.gildehealthcare.com.

Categories: News

Investment in TSE, an expert in Photovoltaic and Agrivoltaic development

Eurazeo

Eurazeo is investing in TSE through its Transition Infrastructure Fund. Bpifrance and investors from the Crédit Agricole group are also taking part in this €130 million fundraising round.

TSE was founded in 2016 and is a producer of solar energy in France. Its ambition is to meet the challenges posed by energy and ecological transition, partly by developing agrivoltaic projects through partnerships with major players in the world of agriculture. TSE is also recognised for its innovative agricultural canopy solution, and is the company that brought into service the Marville photovoltaic facility, the second-largest in France. TSE currently has 1.6 GW of projects at varying stages of development.
This fundraising round, led by Eurazeo, is intended to support the company’s growth and help it develop large-scale photovoltaic and agrivoltaic projects. TSE’s aim is to reinforce its significant presence in this field by developing strong local roots, close ties with the farming community and a resolute focus on innovation.

Through this investment – the fifth made by Eurazeo’s Infrastructure team – Eurazeo is pursuing its ESG and sustainability targets while supporting energy transition and contributing to a low-carbon economy.
Mathieu Debonnet and Pierre Yves Lambert, who jointly lead TSE, said:
“We are delighted to welcome Eurazeo, Bpifrance and Crédit Agricole as shareholders. Their investment will help to boost our growth and is a major source of pride for us. It also demonstrates the strength of our business model, products, innovations and know-how in the field of solar power. We will continue to develop according to our business model based on quality, a focus on the long term, a grass-roots commitment to farmers and manufacturers and an environment-focused culture. More than ever, we will play an active role in decarbonising our economy and increasing its resilience. We thank our new investors for the confidence they have shown in TSE’s plans.”

Melissa Cohen, Managing Director of Eurazeo’s Infrastructure team, added:
“We are delighted to be partnering with TSE, a producer of photovoltaic energy whose products combine the benefits of solar power and agricultural development, and which can be adapted to all types of terrain. This fundraising round will give it the resources it needs to fulfil its ambitions. We are happy to be taking part in TSE’s entrepreneurial journey, and particularly its development of innovative agrivoltaic solutions. TSE’s market position is entirely aligned with Eurazeo’s commitment to energy transition.”

Categories: News

Tags:

Gimv leads a 72 million € Series A financing round of Complement Therapeutics to finance further development of therapies for eye diseases

GIMV

17/04/2023 – 07:27 | Portfolio

Complement Therapeutics announces the closing of a 72 million € Series A financing round led by Gimv together with existing investor Forbion and further joined by BioGeneration Ventures (BGV), Panakes Partners, Cambridge Innovation Capital (CIC), Hadean Ventures and Seroba Life Sciences. Complement Therapeutics will use the proceeds of this round to continue to develop its innovative therapies for the treatment of complement-related diseases, with particular focus on ophtalmology.

Complement Therapeutics, a spin-out of the University of Manchester founded in 2021, aims to transform the treatment of complement-mediated conditions by developing novel therapies such as CTx001, an innovative AAV gene therapy for the treatment of geographic atrophy, a progressive and advanced form of age-related macular degeneration (AMD) associated with significant, irreversible loss of vision.

Furthermore, the financing round will allow Complement Therapeutics to evaluate its pipeline assets for non-ocular indications as well as further develop the novel Complement Precision Medicine (CPM) platform.

Michaël Vlemmix, Principal Life Sciences at Gimv and Board Director at CTx comments: “One of the pillars of our Life Sciences strategy is to invest in companies where cutting-edge science could lead to a potential paradigm shift in the treatment and lives of patients.  Complement Therapeutics is a key example of such an investment whereby we are proud to have been able to build a strong syndicate, supported by a high-quality current investor base.

Rishabh Chawla, Associate of Gimv’s Life Sciences team and Observer at CTx adds:“With the ability to target the etiology of complement-related diseases along with a very experienced and dedicated management team, we are convinced that Complement Therapeutics will make a real difference to patients that have limited treatment options today.

For more information, please read the full press release from Complement Therapeutics attached.

Categories: News

Tags: